Is There an Age Threshold for Active Surveillance in Highly Suspicious Subcentimeter Thyroid Nodules?

Affiliations

¹ Department of Surgical Oncology, Center for Endocrine Tumors, Saint John's (Formerly John Wayne) Cancer Institute, Santa Monica, CA, USA.
² Department of Surgical Oncology, Center for Endocrine Tumors, Saint John's (Formerly John Wayne) Cancer Institute, Santa Monica, CA, USA. melaniegoldfarbmd@gmail.com.

Editorial

Stephanie Young et al. Ann Surg Oncol. 2023 Sep.

. 2023 Sep;30(9):5318-5319.

doi: 10.1245/s10434-023-13682-2. Epub 2023 May 26.

¹ Department of Surgical Oncology, Center for Endocrine Tumors, Saint John's (Formerly John Wayne) Cancer Institute, Santa Monica, CA, USA.
² Department of Surgical Oncology, Center for Endocrine Tumors, Saint John's (Formerly John Wayne) Cancer Institute, Santa Monica, CA, USA. melaniegoldfarbmd@gmail.com.

No abstract available

References

1. Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34. - DOI - PubMed - PMC
1. Brito JP, Ito Y, Miyauchi A, Tuttle RM. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid. 2016;26(1):144–9. - DOI - PubMed - PMC
1. Zhuge L, Huang Z, Cai H, Wang S, Niu L, Li Z. The Optimal Threshold of Age for Stratifying the Risks of Disease Progression in Patients with Highly Suspicious Subcentimeter Thyroid Nodules. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13497-1 .
1. Miyauchi A, Kudo T, Ito Y, et al. Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance. Surgery. 2018;163(1):48–52. - DOI - PubMed
1. Lee EK, Moon JH, Hwangbo Y, et al. Progression of low-risk papillary thyroid microcarcinoma during active surveillance: interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma in Korea. Thyroid. 2022;32(11):1328–36. - DOI - PubMed - PMC